Reference number : 236-2012-2013-Q4-00096, amendment number : , agreement type : G, recipient legal name : SCHMELING, Heinrike, recipient country : CA, recipient province : AB, recipient city : Calgary, recipient postal code : T2N 1N4, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 280000.0, agreement start date : 2013-03-01, agreement end date : 2015-02-28, description english : Pharmacogenetics of juvenile idiopathic arthritis: A genome wide association study on the efficacy and toxicity of methotrexate and etanercept therapy, description french : Pharmacogenetics of juvenile idiopathic arthritis: A genome wide association study on the efficacy and toxicity of methotrexate and etanercept therapy, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2012-13 to 2014-15), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2012-13 à 2014-15), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada